Rat GM-CSF Platinum ELISA

Description: The rat GM-CSF ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of rat GM-CSF. The rat GM-CSF ELISA is for research use only. Not for diagnostic or therapeutic procedures.

GM-CSF is a small glycoprotein growth factor which stimulates the production and function of neutrophils, eosinophils and monocytes GM-CSF can be produced by a wide variety of tissue types, including fibroblasts, endothelial cells, T-cells, macrophages, mesothelial cells, epithelial cells and many types of tumor cells. In most of these tissues, inflammatory mediators, such as interleukin-1, interleukin-6, tumor necrosis, factor or endotoxin, are patent inducers of GM-CSF gene expression, which occurs at least partly by post-transcriptional modification of the GM-CSF mRNA.

The biological effects of GM-CSF are mediated through binding to cell surface receptors, which appear to be widely expressed by hematopoietic cells and also by some non-hematopoietic cells, such as endothelial cells. At least two different functional classes of GM-CSF receptor have been identified. The neutrophil GM-CSF receptor exclusively binds GM-CSF, while interleukin-3 competes for binding of GM-CSF to a second class of receptors detected on some leukemic cell lines.

References: Bolwell,B.J.. The use of G-CSF and GM-CSF in bone marrow transplantation. Cleve.Clin.J.Med. 1993;60:291-302. (Link)

Groves,R.W.; Schmidt-Lucke,J.A.. Recombinant human GM-CSF in the treatment of poorly healing wounds. Adv.Skin Wound.Care 2000;13:107-112. (Link)

Toren,A.; Nagler,A.. The implications of granulocyte-monocyte colony-stimulating factor (GM-CSF) in cytotoxicity of bone marrow transplantation. Cytokines Cell Mol.Ther. 1998;4:199-206. (Link)

Burgess,A.W.; Metcalf,D.. The nature and action of granulocyte-macrophage colony stimulating factors. Blood 1980;56:947-958. (Link)

Ross,S.D.; DiGeorge,A.; Connelly,J.E.; Whiting,G.W.; McDonnell,N.. Safety of GM-CSF in patients with AIDS: a review of the literature. Pharmacotherapy 1998;18:1290-1297. (Link)

Lim,M.; Simons,J.W.. Emerging concepts in GM-CSF gene-transduced tumor vaccines for human prostate cancer. Curr.Opin.Mol Ther. 1999;1:64-71. (Link)

Drings,P.; Fischer,J.R.. Biology and clinical use of GM-CSF in lung cancer. Lung 1990;168 Suppl:1059-1068. (Link)

Freund,M.; Kleine,H.D.. The role of GM-CSF in infection. Infection 1992;20 Suppl 2:S84-S92. (Link)

Lowenberg,B.; de Greef,G.E.; Wielenga,J.J.. Granulocyte-macrophage colony stimulating factor (GM-CSF) in the treatment of hematological malignancies. Anticancer Drugs 1993;4 Suppl 1:17-20. (Link)

Jones,T.C.. Use of granulocyte-macrophage colony stimulating factor (GM-CSF) in prevention and treatment of fungal infections. Eur.J.Cancer 1999;35 Suppl 3:S8-10. (Link)

Griffin,J.D.; Cannistra,S.A.; Sullivan,R.; Demetri,G.D.; Ernst,T.J.; Kanakura,Y.. The biology of GM-CSF: regulation of production and interaction with its receptor. Int.J.Cell Cloning 1990;8 Suppl 1:35-44. (Link)

Harmenberg,J.; Hoglund,M.; Hellstrom-Lindberg,E.. G- and GM-CSF in oncology and oncological haematology. Eur.J.Haematol.Suppl 1994;55:1-28. (Link)

Hejna,M.; Brodowicz,T.; Zielinski,C.C.. Local use of GM-CSF for severe mucositis. Eur.J.Cancer 1999;35 Suppl 3:S14-S17. (Link)

Harousseau,J.L.; Wu,D.. The use of GM-CSF and G-CSF in the treatment of acute leukemias. Leuk.Lymphoma 1995;18:405-412. (Link)

Hoshi,S.; Yoshizawa,A.; Arioka,H.; Kobayashi,N.; Kudo,K.; Niino,H.. [Anaplastic thyroid carcinoma with lung metastasis producing CA 19-9 and GM-CSF]. Nihon Kokyuki.Gakkai Zasshi 2000;38:391-397. (Link)